Galaxy Medicare (NSE:GML) EV-to-FCF: 114.00 (As of Jul. 04, 2026) — 1203% Above Median


NSE:GML Galaxy Medicare Ltd NSE:GML
19 GF Score
Price ₹18.30
! 2 Warning Signs
View Full Analysis

What is Galaxy Medicare EV-to-FCF?

Galaxy Medicare NSE:GML 19 EV-to-FCF is 114.00 as of Jul. 04, 2026, which is 1203% above its 10-year median of 8.75. GuruFocus rates NSE:GML with a GF Score™ of 19/100. The stock has 2 warning signs investors should review. Among 418 Medical Devices & Instruments companies, Galaxy Medicare ranks worse than 87.08% on this metric.

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Galaxy Medicare's Enterprise Value is ₹186.5 Mil. Galaxy Medicare's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹1.6 Mil. Therefore, Galaxy Medicare's EV-to-FCF for today is 114.00.

The historical rank and industry rank for Galaxy Medicare's EV-to-FCF or its related term are showing as below:

NSE:GML' s EV-to-FCF Range Over the Past 10 Years
Min: 6.53   Med: 8.75   Max: 130.01
Current: 109.82

During the past 5 years, the highest EV-to-FCF of Galaxy Medicare was 130.01. The lowest was 6.53. And the median was 8.75.

NSE:GML's EV-to-FCF is ranked worse than
87.08% of 418 companies
in the Medical Devices & Instruments industry
Industry Median: 23.12 vs NSE:GML: 109.82

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-07-04), Galaxy Medicare's stock price is ₹18.30. Galaxy Medicare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹2.251. Therefore, Galaxy Medicare's PE Ratio (TTM) for today is 8.13.


Galaxy Medicare  (NSE:GML) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Galaxy Medicare's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=18.30/2.251
=8.13

Galaxy Medicare's share price for today is ₹18.30.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Galaxy Medicare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹2.251.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Galaxy Medicare EV-to-FCF Related Terms


Galaxy Medicare EV-to-FCF Historical Data

* Premium members only.

The historical data trend for Galaxy Medicare's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Galaxy Medicare EV-to-FCF Chart

Galaxy Medicare Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
EV-to-FCF
0.00 0.00 0.00 0.00 97.51

Galaxy Medicare Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
EV-to-FCF Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 97.51

NSE:GML vs ISRG, BDX, MDLN: EV-to-FCF Comparison

For the Medical Instruments & Supplies subindustry, Galaxy Medicare's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Galaxy Medicare EV-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Galaxy Medicare's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Galaxy Medicare's EV-to-FCF falls into.


NSE:GML
19GF Score
Galaxy Medicare Ltd NSE:GML
EV-to-FCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Galaxy Medicare EV-to-FCF Calculation

Galaxy Medicare's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=186.500/1.636
=114.00

Galaxy Medicare's current Enterprise Value is ₹186.5 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Galaxy Medicare's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹1.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EV-to-FCF →
What does a EV-to-FCF of 114.00 mean?
Galaxy Medicare (NSE:GML) has a EV-to-FCF of 114.00 as of Jul. 04, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Galaxy Medicare and its competitors. This is 1203% above median its historical median of 8.75. Over the past decade, Galaxy Medicare's EV-to-FCF has ranged from 6.53 to 130.01. According to the industry distribution chart, Galaxy Medicare ranks #364 out of 418 companies in the Medical Devices & Instruments industry, placing it in the top 87.1%.
Is Galaxy Medicare's EV-to-FCF too high?
Galaxy Medicare's current EV-to-FCF of 114.00 is 1203% above median its 10-year median of 8.75. Over the past 10 years, this metric has ranged from a low of 6.53 to a high of 130.01. The Medical Devices & Instruments industry median EV-to-FCF is 23.12. Galaxy Medicare's value of 114.00 is 393.1% above this industry median. Based on the distribution chart, Galaxy Medicare ranks #364 out of 418 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Galaxy Medicare has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Galaxy Medicare's EV-to-FCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Galaxy Medicare ranks #364 out of 418 companies for EV-to-FCF. This places Galaxy Medicare in the lower half of its industry. The industry median EV-to-FCF is 23.12. Galaxy Medicare's value of 114.00 is 393.1% above this benchmark. Historically, Galaxy Medicare's own EV-to-FCF has ranged from 6.53 to 130.01 over the past decade. While the company's 10-year median is 8.75 vs. the industry median of 23.12, Galaxy Medicare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.12, based on 418 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Galaxy Medicare's current EV-to-FCF of 114.00 is 393.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Galaxy Medicare and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Galaxy Medicare's current EV-to-FCF is 114.00, which is 1203% above median its own 10-year median of 8.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Galaxy Medicare stock overvalued right now?
Galaxy Medicare (NSE:GML) has a current EV-to-FCF of 114.00. The current EV-to-FCF is 114.00, which is 1203% above median its 10-year median of 8.75 and 393.1% above the Medical Devices & Instruments industry median of 23.12. Galaxy Medicare's overall GF Score™ is 19/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Galaxy Medicare (NSE:GML), the current EV-to-FCF is 114.00 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Galaxy Medicare Business Description

Address Plot No-2, Zone D, Phase A, Mancheswar Industrial Estate, Khurda, Bhubaneswar, OR, IND, 751010
Galaxy Medicare Ltd is engaged into the manufacturing, trading and exporting of Medical Devices, Plasters of Paris Bandages (POP Bandage) and Other surgical dressings in India. Its business encompass: Manufacturing and Branding of its own products under its flagship brands i.e. POP BAND, POP CAST, G CAST, GYPSOSOFT, GYPSOPLAST, CARETAPE, GYPSOCREPE, CARECREPE, CAREPORE GYPSONET, GYPSOCHLOR, FIXCAN ETC.
19GF Score

Get the complete analysis for NSE:GML

EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹18.30
Price